Cargando…
Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms
A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous syste...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911160/ https://www.ncbi.nlm.nih.gov/pubmed/36789140 http://dx.doi.org/10.1016/j.hest.2023.02.001 |
_version_ | 1784884936950415360 |
---|---|
author | Sarıoğlu, Elif Sarıaltın, Sezen Yılmaz Çoban, Tülay |
author_facet | Sarıoğlu, Elif Sarıaltın, Sezen Yılmaz Çoban, Tülay |
author_sort | Sarıoğlu, Elif |
collection | PubMed |
description | A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous system aside from infecting the respiratory system as its primary target. The most common nervous system symptoms of COVID-19 are stated as headache, myalgia, fatigue, nausea, vomiting, sudden and unexplained anosmia, and ageusia. More severe conditions such as encephalomyelitis, acute myelitis, thromboembolic events, ischemic stroke, intracerebral hemorrhage, Guillain-Barré-syndrome, Bell's palsy, rhabdomyolysis, and even coma have also been reported. Cohort studies revealed that neurological findings are associated with higher morbidity and mortality. The neurological symptoms and manifestations caused by SARS-CoV-2 and COVID-19 are examined and summarized in this article. |
format | Online Article Text |
id | pubmed-9911160 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-99111602023-02-10 Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms Sarıoğlu, Elif Sarıaltın, Sezen Yılmaz Çoban, Tülay Brain Hemorrhages Article A novel coronavirus, severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first identified in December 2019 in Wuhan, China. The new coronavirus disease (COVID-19) was declared a global pandemic by the World Health Organization (WHO) in March 2020. SARS-CoV-2 can invade the nervous system aside from infecting the respiratory system as its primary target. The most common nervous system symptoms of COVID-19 are stated as headache, myalgia, fatigue, nausea, vomiting, sudden and unexplained anosmia, and ageusia. More severe conditions such as encephalomyelitis, acute myelitis, thromboembolic events, ischemic stroke, intracerebral hemorrhage, Guillain-Barré-syndrome, Bell's palsy, rhabdomyolysis, and even coma have also been reported. Cohort studies revealed that neurological findings are associated with higher morbidity and mortality. The neurological symptoms and manifestations caused by SARS-CoV-2 and COVID-19 are examined and summarized in this article. International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. 2023-02-10 /pmc/articles/PMC9911160/ /pubmed/36789140 http://dx.doi.org/10.1016/j.hest.2023.02.001 Text en © 2023 International Hemorrhagic Stroke Association. Publishing services by Elsevier B.V. on behalf of KeAi Communications Co. Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Article Sarıoğlu, Elif Sarıaltın, Sezen Yılmaz Çoban, Tülay Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title | Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title_full | Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title_fullStr | Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title_full_unstemmed | Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title_short | Neurological complications and effects of COVID-19: Symptoms and conceivable mechanisms |
title_sort | neurological complications and effects of covid-19: symptoms and conceivable mechanisms |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9911160/ https://www.ncbi.nlm.nih.gov/pubmed/36789140 http://dx.doi.org/10.1016/j.hest.2023.02.001 |
work_keys_str_mv | AT sarıogluelif neurologicalcomplicationsandeffectsofcovid19symptomsandconceivablemechanisms AT sarıaltınsezenyılmaz neurologicalcomplicationsandeffectsofcovid19symptomsandconceivablemechanisms AT cobantulay neurologicalcomplicationsandeffectsofcovid19symptomsandconceivablemechanisms |